European Market Report for Infusion Pumps 2017 - MedCore

Thursday, November 16, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Nov. 15, 2017 /PRNewswire/ -- General Report Contents

- Market Analyses include: Unit Sales, ASPs,

Market Value & Growth TrendsDownload the full report: Market Drivers & Limiters for each chapter segment- Competitive Analysis for each chapter segment- Section on recent mergers & acquisitionsWhen
patients begin to receive medical treatment, they may require an infusion of fluids at some point. These fluids can contain medication for disease management or pain control, and/or nutrients to compensate for a deficiency, facilitating a faster recovery. Before infusion pumps, fluids would be infused by using a bag and an intravenous (IV) set that used the force of gravity to introduce the fluids into the vasculature through a drip chamber. This was commonly referred to as gravity drip.While this method is effective in administering fluids, it is not always practical for several reasons. Fluids administered via the gravity method have a maximum rate of infusion that may not be ideal when large volumes of fluid need to be infused. Gravity pumps also have a minimum infusion rate that may be too large for certain types of medications. Finally, infusion rates may have to vary depending on the time of day; maintaining an acceptable degree of accuracy with a gravity drip can be difficult.Because of these gravity drip method drawbacks, infusion pumps were introduced and have been used in some capacity since the early 20th century. Since then, infusion pumps have become the dominant method of fluid administration. Several specific infusion pump designs have branched off in order to manage specific needs and concerns during medical treatment.While the use of pumps has provided the added benefit of increasing accuracy, recurrent hardware and software problems have led to concerns over patient safety during infusions. Several warnings of product recalls have been issued that led to the replacement of all pumps installed by a leading manufacturer and cessation of new pump sales by another leading supplier.The Committee for Medicinal Products for Human Use (CHMP), the division of the European Medicines Agency's committee responsible for elaborating the agency's opinions on all issues regarding medicinal products for human use, has a report outlining key areas that need to be addressed in order to improve infusion processes and devices.AbstractThis market includes large volume, syringe, electronic ambulatory and disposable ambulatory infusion pump segments. Growth in the total market will be driven primarily by increases in unit sales of electronic ambulatory infusion pumps which have a higher than average ASP. Market growth will be hindered by overall reduction in ASP as a result of intensified competition for less frequent tenders.Scope2013-2023Download the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +44 208 816 85 48 Website:

View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store